CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
Laura Kapitza(German Cancer Research Center), Jessica Hartmann(Paul Ehrlich Institut)
Cited by 10
Related Papers
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
|Frontiers in Immunology|2020|111
Immunotherapy with NK cells: recent developments in gene modification open up new avenues
|OncoImmunology|2020|41